[
  {
    "text": "hello everyone thank you for attending today's webinar CPT is comprehensive",
    "start": "3819",
    "end": "10130"
  },
  {
    "text": "guide to mobile technologies in clinical trials presented by Amazon Web Services",
    "start": "10130",
    "end": "15530"
  },
  {
    "text": "I'm Lida Pham the worldwide head of Life Sciences for AWS and I'll be moderating",
    "start": "15530",
    "end": "21349"
  },
  {
    "text": "this webinar just a few technical notes before we begin if you'd like to",
    "start": "21349",
    "end": "26720"
  },
  {
    "text": "download the slide deck please click the resources list button at the bottom of your screen the webcast is being",
    "start": "26720",
    "end": "35090"
  },
  {
    "text": "streamed through your computer so there is no dial in number for the best audio",
    "start": "35090",
    "end": "40430"
  },
  {
    "text": "quality please make sure your volume is up you can find additional answers to",
    "start": "40430",
    "end": "46490"
  },
  {
    "text": "some common technical issues located in the health button at the bottom of your screen this webinar is being recorded",
    "start": "46490",
    "end": "53510"
  },
  {
    "text": "and will be available on demand within 24 hours after the event and we will",
    "start": "53510",
    "end": "59899"
  },
  {
    "text": "follow the presentations with a Q&A session please submit your questions using the Q&A button on the left side of",
    "start": "59899",
    "end": "67250"
  },
  {
    "text": "your screen so in my role I work with pharmaceutical",
    "start": "67250",
    "end": "72680"
  },
  {
    "text": "biotech medical devices and CRO s to help accelerate transformation in the",
    "start": "72680",
    "end": "79220"
  },
  {
    "text": "industry I was honored to be a part of the C TTI initiative to develop and",
    "start": "79220",
    "end": "85040"
  },
  {
    "text": "disseminate these comprehensive guidelines produced as mobile technologies and clinical trials not",
    "start": "85040",
    "end": "91430"
  },
  {
    "text": "only will these help us embrace the growing use of mobile technologies by consumers to help achieve health and",
    "start": "91430",
    "end": "97610"
  },
  {
    "text": "wellness goals but they will also enable us to make the clinical trial experience much more patient centric enabling",
    "start": "97610",
    "end": "104990"
  },
  {
    "text": "greater inclusion of patients into trials and providing us with insights into disease states that we've never had",
    "start": "104990",
    "end": "111439"
  },
  {
    "text": "before AWS founded our healthcare and life sciences vertical almost 5 years ago now",
    "start": "111439",
    "end": "117500"
  },
  {
    "text": "and we've been in the unique position of understanding the needs of health care providers and payers and translating",
    "start": "117500",
    "end": "124189"
  },
  {
    "text": "those needs to our customers and life sciences so they can play a stronger role in its rapidly evolving healthcare",
    "start": "124189",
    "end": "130729"
  },
  {
    "text": "system Clinic trials is an important area for us we",
    "start": "130729",
    "end": "137829"
  },
  {
    "text": "believe that while we are living in a golden age of drug discovery and innovation the tools that researchers",
    "start": "137829",
    "end": "144670"
  },
  {
    "text": "have access to were designed for a very different era technology such as cloud computing",
    "start": "144670",
    "end": "150480"
  },
  {
    "text": "Internet of Things artificial intelligence and machine learning can",
    "start": "150480",
    "end": "156040"
  },
  {
    "text": "help us redesign the process so we can ensure that these new novel medications",
    "start": "156040",
    "end": "161650"
  },
  {
    "text": "reach patients as quickly and as safely as possible what's exciting is that",
    "start": "161650",
    "end": "167829"
  },
  {
    "text": "we're seeing innovation happening along the entire clinical trial process with tools emerging to help develop smarter",
    "start": "167829",
    "end": "174849"
  },
  {
    "text": "protocol protocol to help data to be exchanged with healthcare providers to accelerate recruiting and to enable use",
    "start": "174849",
    "end": "182170"
  },
  {
    "text": "of artificial intelligence and machine learning to eliminate the commodity low value task of repetitive data entry",
    "start": "182170",
    "end": "189299"
  },
  {
    "text": "reduce errors and provide actionable insights with these guidelines we",
    "start": "189299",
    "end": "196209"
  },
  {
    "text": "believe we have the first roadmap to helping researchers around the world clearly understand when and how to use",
    "start": "196209",
    "end": "202959"
  },
  {
    "text": "mobile technologies and clinical trials demystifying everything from collection",
    "start": "202959",
    "end": "208510"
  },
  {
    "text": "of the devices access and utilization of the data engagement of patients and",
    "start": "208510",
    "end": "214440"
  },
  {
    "text": "evaluation of the results so it's my honor today to introduce three members",
    "start": "214440",
    "end": "221470"
  },
  {
    "text": "of the group who will help us understand these guidelines from the perspective of patients researchers and regulatory",
    "start": "221470",
    "end": "229060"
  },
  {
    "text": "bodies dr. ray Dorsey is the David M levy professor of neurology and director",
    "start": "229060",
    "end": "234790"
  },
  {
    "text": "of the Center for health and technology at the University of Rochester through creative use of technology pianist",
    "start": "234790",
    "end": "241449"
  },
  {
    "text": "colleagues seek to enable anyone anywhere to receive care participated research and benefit from therapeutic",
    "start": "241449",
    "end": "248500"
  },
  {
    "text": "advances Linda Ritchie started her career in the FDA in 2005 and has had",
    "start": "248500",
    "end": "255010"
  },
  {
    "text": "several roles including scientific reviewer and branch chief within the division of cardiovascular devices",
    "start": "255010",
    "end": "260459"
  },
  {
    "text": "currently miss ritchi is the associate director for digital health within the office of device evaluation",
    "start": "260459",
    "end": "268449"
  },
  {
    "text": "Ronson is the senior vice president a research strategy at parent project muscular dystrophy a patient advocacy",
    "start": "268449",
    "end": "276099"
  },
  {
    "text": "organization dedicated to improving the lives of those who Duchenne previously",
    "start": "276099",
    "end": "281169"
  },
  {
    "text": "she was the director of operation at the CTSA program at the NIH okay now let's begin ray over to you",
    "start": "281169",
    "end": "289120"
  },
  {
    "text": "thank you Leda so the last decade had seen an",
    "start": "289120",
    "end": "295689"
  },
  {
    "text": "exponential increase in the use of digital tools to measure health and just",
    "start": "295689",
    "end": "301449"
  },
  {
    "text": "looking at the number of published studies of accelerometers over the last sixty or seventy years you can see that",
    "start": "301449",
    "end": "307180"
  },
  {
    "text": "this is really a phenomenon of the last ten years and the group at City recently",
    "start": "307180",
    "end": "314229"
  },
  {
    "text": "published a system systematic review of mobile technologies and the new journal digital biomarkers and that work they",
    "start": "314229",
    "end": "321219"
  },
  {
    "text": "defied 88 studies that evaluated mobile technologies to measure health and the",
    "start": "321219",
    "end": "327339"
  },
  {
    "text": "most common therapeutic areas for evaluation were in cardiology and dive",
    "start": "327339",
    "end": "332349"
  },
  {
    "text": "cardiology diabetes and sleep which accounted for about half the studies you can see about 10 different therapeutic",
    "start": "332349",
    "end": "339909"
  },
  {
    "text": "areas ranging from cancer to arthritis to nutrition were subject to evaluation",
    "start": "339909",
    "end": "346300"
  },
  {
    "text": "and importantly one quarter of these 88 studies were evaluated mobile",
    "start": "346300",
    "end": "351370"
  },
  {
    "text": "technologies in the context of an interventional trial in my field of",
    "start": "351370",
    "end": "357069"
  },
  {
    "text": "neurology you've seen a similar exponential increase in the evaluation of smartphones and wearable sensors to",
    "start": "357069",
    "end": "364569"
  },
  {
    "text": "evaluate neurological disorders and just a month ago Roche pharmaceuticals",
    "start": "364569",
    "end": "370300"
  },
  {
    "text": "published the use of a smartphone as an exploratory outcome measure in a Phase",
    "start": "370300",
    "end": "375879"
  },
  {
    "text": "one clinical trial and in that study Roche used a smartphone to measure",
    "start": "375879",
    "end": "382469"
  },
  {
    "text": "features of Parkinson's disease such as date voice and balance ensure that this",
    "start": "382469",
    "end": "388839"
  },
  {
    "text": "was feasible that the least adherent participants use the smartphone on 40%",
    "start": "388839",
    "end": "394719"
  },
  {
    "text": "of the days that were requested and have now you advanced the smartphone into an",
    "start": "394719",
    "end": "401019"
  },
  {
    "text": "ongoing fee to clinical trial given the rapid",
    "start": "401019",
    "end": "406420"
  },
  {
    "text": "interest in the use of mobile technologies city organizing multi-stakeholder process to provide",
    "start": "406420",
    "end": "412720"
  },
  {
    "text": "guidance on the use of mobile technologies and clinical trials city or the clinical trials transformation",
    "start": "412720",
    "end": "418720"
  },
  {
    "text": "initiative is the brainchild of the cardiologist and former FDA Commissioner dr. Robert Calif when he was at Duke",
    "start": "418720",
    "end": "425500"
  },
  {
    "text": "University and as a public-private partnership between the Duke University",
    "start": "425500",
    "end": "430630"
  },
  {
    "text": "and the FDA and its mission is to develop and drive adoption of practices that will increase the quality and",
    "start": "430630",
    "end": "437110"
  },
  {
    "text": "efficiency of clinical trials to that",
    "start": "437110",
    "end": "442480"
  },
  {
    "text": "end city's efforts are focused broadly on increasing the quality and efficiency",
    "start": "442480",
    "end": "447580"
  },
  {
    "text": "of trials through multiple different efforts and the mobile clinical trials effort is just one example the purpose",
    "start": "447580",
    "end": "457330"
  },
  {
    "text": "of a mobile clinical trials program was to develop evidence-based recommendations that effect the",
    "start": "457330",
    "end": "462730"
  },
  {
    "text": "widespread adoption and use of mobile technology and clinical trials for regulatory submission and had four",
    "start": "462730",
    "end": "468700"
  },
  {
    "text": "pillars that were part of it one using mobile measures to develop novel or new endpoints for clinical studies two to",
    "start": "468700",
    "end": "476170"
  },
  {
    "text": "use to focus on data issues around the use of mobile technologies three to",
    "start": "476170",
    "end": "481510"
  },
  {
    "text": "engage stakeholders in the process and four to begin thinking about decentralization of clinical trials true",
    "start": "481510",
    "end": "490240"
  },
  {
    "text": "to their focus on a multi-stakeholder process the project team for this effort",
    "start": "490240",
    "end": "496030"
  },
  {
    "text": "included representations from patients or the research participants technology",
    "start": "496030",
    "end": "501580"
  },
  {
    "text": "firms pharmaceutical firms academic researchers and the government especially FDA and NIH so why do we need",
    "start": "501580",
    "end": "513130"
  },
  {
    "text": "them mobile technologies and the short answer is because in many disease areas",
    "start": "513130",
    "end": "518469"
  },
  {
    "text": "the current measures are rater dependent subjective episodic and conducted only",
    "start": "518469",
    "end": "524830"
  },
  {
    "text": "in clinic and what we really need are participant-centered measures that are",
    "start": "524830",
    "end": "530140"
  },
  {
    "text": "objective frequent and real-world and my field of Parkinson disease",
    "start": "530140",
    "end": "535740"
  },
  {
    "text": "we read pregnancies right now is we have individuals tap their thumb and indexfinger as big and fast as they can",
    "start": "535740",
    "end": "541560"
  },
  {
    "text": "ten times and experts like me rate that on a categorical scale that goes from",
    "start": "541560",
    "end": "547529"
  },
  {
    "text": "zero to four obviously we have digital tools that can measure that objectively",
    "start": "547529",
    "end": "553370"
  },
  {
    "text": "precisely and in wide range of settings outside the clinic not surprisingly our",
    "start": "553370",
    "end": "561750"
  },
  {
    "text": "current understanding of many conditions is very limited to to what we see in the",
    "start": "561750",
    "end": "567450"
  },
  {
    "text": "clinic when in reality participants have their diseases 24 hours a day seven days",
    "start": "567450",
    "end": "573600"
  },
  {
    "text": "a week and we currently have very limited means of measuring the 99.9% of",
    "start": "573600",
    "end": "580200"
  },
  {
    "text": "time research participants are not in the clinic just in a simple examples you know think about how blood glucose",
    "start": "580200",
    "end": "586950"
  },
  {
    "text": "measurements have transformed the care and research for individuals with diabetes we wouldn't dose individuals",
    "start": "586950",
    "end": "595950"
  },
  {
    "text": "insulin for the next three months based on a single recording done and clinic",
    "start": "595950",
    "end": "602959"
  },
  {
    "text": "the recommendations that city came up with through the mobile clinical trials effort are focused on five areas one on",
    "start": "603350",
    "end": "610620"
  },
  {
    "text": "the selection of mobile technology what digital tools should be used to measure the outcomes that are desired to the",
    "start": "610620",
    "end": "618209"
  },
  {
    "text": "data collection analysis and interpretation three data management for",
    "start": "618209",
    "end": "623339"
  },
  {
    "text": "protocol design and execution and five FDA submission and inspection on the",
    "start": "623339",
    "end": "630660"
  },
  {
    "text": "balance of the call Linda Ritchie's going to talk to us about the selection of mobile technologies Abbi Bronson is",
    "start": "630660",
    "end": "637110"
  },
  {
    "text": "going to discuss participant engagement as a prerequisite for success I'm going to return briefly to highlight some",
    "start": "637110",
    "end": "642870"
  },
  {
    "text": "additional resources available to you and then leave is going to lead us through a discussion and question and answer session I am now delighted to",
    "start": "642870",
    "end": "650190"
  },
  {
    "text": "introduce Linda Ritchie from the FDA",
    "start": "650190",
    "end": "653959"
  },
  {
    "text": "thanks ray good afternoon I would like to share with you the city",
    "start": "655850",
    "end": "661680"
  },
  {
    "text": "recommendations regarding mobile technology selection before we get",
    "start": "661680",
    "end": "666720"
  },
  {
    "text": "started I want to make sure that we are all on the same with regards to the definition of mobile",
    "start": "666720",
    "end": "672330"
  },
  {
    "text": "technology in this context the mobile clinical trials mobile technology team has defined mobile technologies as",
    "start": "672330",
    "end": "679590"
  },
  {
    "text": "mobile applications and other wearables adjustables and plantable and portable technologies containing",
    "start": "679590",
    "end": "686460"
  },
  {
    "text": "sensors for the remote capture of outcomes data with this in mind let's",
    "start": "686460",
    "end": "692070"
  },
  {
    "text": "get started there are five",
    "start": "692070",
    "end": "698220"
  },
  {
    "text": "recommendations regarding how to select an appropriate mobile technology as shown on the slide the first recommendation is to know what",
    "start": "698220",
    "end": "706050"
  },
  {
    "text": "you want to measure before selecting your mobile technology select your tool",
    "start": "706050",
    "end": "711180"
  },
  {
    "text": "based on what you want to measure rather than selecting what you want to measure based on your tool by identifying what",
    "start": "711180",
    "end": "718740"
  },
  {
    "text": "you want to measure prior to selecting a tool the technology selected can be",
    "start": "718740",
    "end": "724260"
  },
  {
    "text": "chosen due to its ability to perform the measurement in the best way possible for your study based on your limitations",
    "start": "724260",
    "end": "731960"
  },
  {
    "text": "this ties very closely to the second recommendation which is that the mobile technology selection should be",
    "start": "731960",
    "end": "738270"
  },
  {
    "text": "specification driven and collaborative the collaboration here involves both the",
    "start": "738270",
    "end": "743700"
  },
  {
    "text": "technology company and patients specifically the selection should be driven by the technical performance the",
    "start": "743700",
    "end": "750060"
  },
  {
    "text": "study needs and the preference of study participants this slide illustrates the",
    "start": "750060",
    "end": "760230"
  },
  {
    "text": "specifications for sponsors to consider the technical performance specifications",
    "start": "760230",
    "end": "765660"
  },
  {
    "text": "are divided into measurement performance and mobile technology communication and data transfer with regards to",
    "start": "765660",
    "end": "772830"
  },
  {
    "text": "measurement performance specifications such as accuracy precision sampling",
    "start": "772830",
    "end": "778560"
  },
  {
    "text": "frequency resolution data processing and metadata should be considered it's also",
    "start": "778560",
    "end": "785550"
  },
  {
    "text": "important to keep in mind that the measurement chosen should inform the specifications the communications and",
    "start": "785550",
    "end": "793020"
  },
  {
    "text": "data transfer specifications considerations include app pairing and",
    "start": "793020",
    "end": "798210"
  },
  {
    "text": "transfer to data gathering platforms data management specifications generally",
    "start": "798210",
    "end": "805350"
  },
  {
    "text": "include card11 and specific data access for things such as mobile technology manufacturer action",
    "start": "805350",
    "end": "812850"
  },
  {
    "text": "access to study data sponsor access to study data and third-party access to",
    "start": "812850",
    "end": "818699"
  },
  {
    "text": "study data we will be discussing this more on the next slide study participant",
    "start": "818699",
    "end": "825149"
  },
  {
    "text": "safety is paramount and appropriate specification should be developed for this the human factor specification",
    "start": "825149",
    "end": "832949"
  },
  {
    "text": "should be informed by the participant population specifications to consider",
    "start": "832949",
    "end": "838699"
  },
  {
    "text": "include acceptability tolerability and usability operational",
    "start": "838699",
    "end": "848830"
  },
  {
    "text": "specifications may include failure rates battery life and firmware performance",
    "start": "848830",
    "end": "854470"
  },
  {
    "text": "and lastly non operational specifications can include cost and customer service returning back today",
    "start": "854470",
    "end": "867640"
  },
  {
    "text": "to access this one may not be as obvious as some of the other items when using",
    "start": "867640",
    "end": "873580"
  },
  {
    "text": "mobile technology is important to remember that the technology manufacturer themselves may not provide",
    "start": "873580",
    "end": "879850"
  },
  {
    "text": "all the data that is collected by that technology to this end and prior to",
    "start": "879850",
    "end": "885160"
  },
  {
    "text": "selecting a technology is important to consider one whether you will have access to the raw data that's generated",
    "start": "885160",
    "end": "892240"
  },
  {
    "text": "by the mobile technology and whether you need it to what levels of the process",
    "start": "892240",
    "end": "898600"
  },
  {
    "text": "data are accessible by the technology and again what is needed for your study",
    "start": "898600",
    "end": "903720"
  },
  {
    "text": "3 if the algorithm used to process the data is accessible and for the format of",
    "start": "903720",
    "end": "910810"
  },
  {
    "text": "the data so in summary when determining",
    "start": "910810",
    "end": "918730"
  },
  {
    "text": "what is needed for a study with regards to data access consider how the data generated by the mobile technology will",
    "start": "918730",
    "end": "926380"
  },
  {
    "text": "be accessed and used by the manufacturer and also what data will be provided to",
    "start": "926380",
    "end": "932830"
  },
  {
    "text": "use the trial sponsor the city recommendation is to ensure that the",
    "start": "932830",
    "end": "938020"
  },
  {
    "text": "access to data meets your needs prior to contracting an electronic service vendor",
    "start": "938020",
    "end": "945570"
  },
  {
    "text": "moving on to next recommendation City recommends that a technology regulatory status not be",
    "start": "948360",
    "end": "955160"
  },
  {
    "text": "the sole driver in sponsors decisions about which mobile technology to use in other words for use within a clinical",
    "start": "955160",
    "end": "962720"
  },
  {
    "text": "trial a mobile technology does not typically need to be cleared or approved as a medical device many mobile",
    "start": "962720",
    "end": "969590"
  },
  {
    "text": "technologies are considered consumer products that are still very useful as data collection tools and clinical",
    "start": "969590",
    "end": "974900"
  },
  {
    "text": "investigations the next recommendation is disregard to verification and",
    "start": "974900",
    "end": "980960"
  },
  {
    "text": "validation the appropriateness of the selected mobile technology should be justified through verification and",
    "start": "980960",
    "end": "987470"
  },
  {
    "text": "validation processes let's explore this a bit more verification in this context",
    "start": "987470",
    "end": "997100"
  },
  {
    "text": "refers to the assessment of accuracy precision consistency over time",
    "start": "997100",
    "end": "1002340"
  },
  {
    "text": "uniformity across mobile technologies and potentially user environmental conditions this is really an engineering",
    "start": "1002340",
    "end": "1009790"
  },
  {
    "text": "assessment verification should demonstrate a lack of errors for the firmware for the firmware that processes",
    "start": "1009790",
    "end": "1017950"
  },
  {
    "text": "the sensor data the test criteria that is often used as a physical bench standard typical variances in the sensor",
    "start": "1017950",
    "end": "1026290"
  },
  {
    "text": "measurements are less than 1% and this information is typically provided by the",
    "start": "1026290",
    "end": "1032260"
  },
  {
    "text": "technology manufacturer themselves in",
    "start": "1032260",
    "end": "1039120"
  },
  {
    "text": "contrast validation assures that the process data are suitable for the intended use and patient population in a",
    "start": "1039120",
    "end": "1046449"
  },
  {
    "text": "trial validation is really a biological assessment the assessment of the",
    "start": "1046450",
    "end": "1052150"
  },
  {
    "text": "accuracy and precision of the biological endpoints that are derived from the sensor data this is usually measured",
    "start": "1052150",
    "end": "1059080"
  },
  {
    "text": "against an independent standard unlike verification variances and endpoint",
    "start": "1059080",
    "end": "1065890"
  },
  {
    "text": "measurements can be very large but still can be useful and this ends up being a statistical question validation can be",
    "start": "1065890",
    "end": "1073450"
  },
  {
    "text": "provided by the device manufacturer themselves an independent study by a user or a new study for a specific",
    "start": "1073450",
    "end": "1080880"
  },
  {
    "text": "patient population ultimately the study sponsor is responsible for ensuring that the chosen",
    "start": "1080880",
    "end": "1087520"
  },
  {
    "text": "measures are appropriate for use in a trial at this point let's walk through",
    "start": "1087520",
    "end": "1096460"
  },
  {
    "text": "this table as an example the raw data is the output from the physical sensor the",
    "start": "1096460",
    "end": "1102820"
  },
  {
    "text": "processed data is the output from mobile technology firmware and the outcome assessment is the output from the",
    "start": "1102820",
    "end": "1109720"
  },
  {
    "text": "analysis algorithm as has been previously discussed the raw data and the processed data are verified and the",
    "start": "1109720",
    "end": "1116409"
  },
  {
    "text": "outcome assessment is validated in walking through the examples let's start",
    "start": "1116409",
    "end": "1122350"
  },
  {
    "text": "with accelerometry the raw data for accelerometry is the acceleration itself",
    "start": "1122350",
    "end": "1128190"
  },
  {
    "text": "the processed data is the activity counts where the outcome assessment",
    "start": "1128190",
    "end": "1133809"
  },
  {
    "text": "could be either the time spent active or the time spent sleeping another examples",
    "start": "1133809",
    "end": "1140559"
  },
  {
    "text": "is ECG the raw data is the electrical potential the process data is the heart",
    "start": "1140559",
    "end": "1147100"
  },
  {
    "text": "rate and the outcome assessment is a heart rate variability",
    "start": "1147100",
    "end": "1153419"
  },
  {
    "text": "lastly the recommendation is that feasibility studies conducted before full",
    "start": "1158760",
    "end": "1163950"
  },
  {
    "text": "implementation in a large study reduce risk these studies can help to address",
    "start": "1163950",
    "end": "1169440"
  },
  {
    "text": "unanticipated challenges associated with the integration of the technology in a clinical trial for a different",
    "start": "1169440",
    "end": "1181260"
  },
  {
    "text": "additional information on these recommendations I encourage you to review the resources listed here thank",
    "start": "1181260",
    "end": "1187559"
  },
  {
    "text": "you for your attention now I would like to turn the presentation over to addy Bronson good",
    "start": "1187559",
    "end": "1197850"
  },
  {
    "text": "afternoon everybody and thanks Linda to start I'd like to thank the organizers for hosting this webinar and this",
    "start": "1197850",
    "end": "1204179"
  },
  {
    "text": "important topic and um it's a pleasure to be here so",
    "start": "1204179",
    "end": "1210510"
  },
  {
    "text": "we've just heard about many of the technological factors to consider when choosing the global technology but all",
    "start": "1210510",
    "end": "1217020"
  },
  {
    "text": "the best decisions can be made in vain if the patient voice isn't appropriately incorporated into the process",
    "start": "1217020",
    "end": "1223710"
  },
  {
    "text": "they're the ones that have to embrace the technology and the data is produces I'm here today to talk about how best to",
    "start": "1223710",
    "end": "1231030"
  },
  {
    "text": "harness the patient's voice and the role of patient engagement in developing a mobile technology and some of the key",
    "start": "1231030",
    "end": "1236970"
  },
  {
    "text": "chains to consider throughout the process just like with any clinical trials the patient's voice should be",
    "start": "1236970",
    "end": "1242370"
  },
  {
    "text": "represented at every stage throughout the trial patients are the experts on their disease and can provide a unique",
    "start": "1242370",
    "end": "1248790"
  },
  {
    "text": "perspective on living with the disease and what matters to them this engagement will make them feel like an active",
    "start": "1248790",
    "end": "1254730"
  },
  {
    "text": "decision-maker they will better understand the research question and thus recruitment and",
    "start": "1254730",
    "end": "1259770"
  },
  {
    "text": "retention will be improved and the data gathers will be of higher quality engagement should take place from the",
    "start": "1259770",
    "end": "1266250"
  },
  {
    "text": "very beginning of trial design and hopefully will be iterative and should continue through dissemination of trial",
    "start": "1266250",
    "end": "1272400"
  },
  {
    "text": "results making adoption of the technology more efficient participant engagement can take many forms from",
    "start": "1272400",
    "end": "1279179"
  },
  {
    "text": "formal qualitative research and focus groups upfront to feasibility technique as we heard just just previously to",
    "start": "1279179",
    "end": "1286410"
  },
  {
    "text": "partnering with patient advocacy organizations such as parent project muscular dystrophy and developing",
    "start": "1286410",
    "end": "1291840"
  },
  {
    "text": "citizen scientists I'm sure some of you who are listening to this hearing you say oh this oh this is going to take time it's",
    "start": "1291840",
    "end": "1298550"
  },
  {
    "text": "gonna slow things down and talked about money but from experience gaining this valuable patient input upfront will save",
    "start": "1298550",
    "end": "1305330"
  },
  {
    "text": "time over the long haul one of the hot topics that's arisen",
    "start": "1305330",
    "end": "1310910"
  },
  {
    "text": "during the development of these guidelines has to do with sharing data generated from the trial back to the",
    "start": "1310910",
    "end": "1316490"
  },
  {
    "text": "patients and being a patient advocate we are very much in support of this notion we are very involved in patient focused",
    "start": "1316490",
    "end": "1323030"
  },
  {
    "text": "drug development and I see data sharing back to patients as PSD becoming full circle but mobile technology presents",
    "start": "1323030",
    "end": "1330050"
  },
  {
    "text": "the unique situation where data sharing can happen in real time so the first consideration is safety to the",
    "start": "1330050",
    "end": "1336740"
  },
  {
    "text": "participant just like in any clinical trial participant safety is the number-one priority so any data sharing",
    "start": "1336740",
    "end": "1343850"
  },
  {
    "text": "in real time pass the exam in this context the question is let any data",
    "start": "1343850",
    "end": "1349280"
  },
  {
    "text": "readouts in real time call calm could they be misinterpreted by the patient not be able to be managed by the",
    "start": "1349280",
    "end": "1356330"
  },
  {
    "text": "patients will they understand what the results mean the body real-time data back can be very motivating to the",
    "start": "1356330",
    "end": "1362810"
  },
  {
    "text": "participants and encourage compliance but it needs to be balanced with what and how much can be provided the second",
    "start": "1362810",
    "end": "1371720"
  },
  {
    "text": "thing to consider is whether real-time data sharing could influence whatever outcome you're measuring and by its",
    "start": "1371720",
    "end": "1377900"
  },
  {
    "text": "study results if there's a reasonable chance that bias could be introduced in our experience participants would rather",
    "start": "1377900",
    "end": "1384230"
  },
  {
    "text": "wait to receive the results post trial if that is what it takes to maximize the",
    "start": "1384230",
    "end": "1389750"
  },
  {
    "text": "possibility that the results won't be confounded I think we sometimes forget what a huge burden being in a trial is",
    "start": "1389750",
    "end": "1396350"
  },
  {
    "text": "travel time to the site's assessment time invade this procedures emotional",
    "start": "1396350",
    "end": "1401570"
  },
  {
    "text": "toll on the family and caregivers wondering if you're on active or placebo with a right decision to be in this",
    "start": "1401570",
    "end": "1408500"
  },
  {
    "text": "trial in the first place it's always heavily on the patients and Families minds in our - any community we had more",
    "start": "1408500",
    "end": "1416000"
  },
  {
    "text": "trial failures than successes and each time the patient community is devastated",
    "start": "1416000",
    "end": "1421220"
  },
  {
    "text": "and heartbroken to receive the news but more importantly they want answers and accounted",
    "start": "1421220",
    "end": "1426800"
  },
  {
    "text": "they want to know why the trial failed the last thing they want to send gone through a trial and have it be all for",
    "start": "1426800",
    "end": "1432980"
  },
  {
    "text": "naught because there was a technical design issue and this might include biased results from Jerry data in real",
    "start": "1432980",
    "end": "1438800"
  },
  {
    "text": "time then would have rather waited and have valid trial results so if there's a question about that I would give you",
    "start": "1438800",
    "end": "1445970"
  },
  {
    "text": "admission wait and not not share all data back real time I think the most",
    "start": "1445970",
    "end": "1452120"
  },
  {
    "text": "important part of this slide is the last bullet point ask your patients if they want results",
    "start": "1452120",
    "end": "1457370"
  },
  {
    "text": "ask them what types of data they would like to receive and when and rash it back if what they want is not possible",
    "start": "1457370",
    "end": "1463190"
  },
  {
    "text": "or my bias results and as a bare minimum offer to review summarized data at the",
    "start": "1463190",
    "end": "1468320"
  },
  {
    "text": "end of the trial and give the overall results whether negative or positive all of this communication even spelling it",
    "start": "1468320",
    "end": "1475160"
  },
  {
    "text": "out in the informed consent are so important for patient communities you will help all aspects of executing a",
    "start": "1475160",
    "end": "1481190"
  },
  {
    "text": "trial and there's let me note no such thing as one sized if they're all mobile technology trial designs in each trial",
    "start": "1481190",
    "end": "1487760"
  },
  {
    "text": "would take hearing the patient voice in deciding what makes sense in terms of providing data ducts while ensuring the",
    "start": "1487760",
    "end": "1494180"
  },
  {
    "text": "integrity of a study data and the safety of the participant to reinforce this",
    "start": "1494180",
    "end": "1501050"
  },
  {
    "text": "this slide shows the results of a study that surveyed did and the pie chart on",
    "start": "1501050",
    "end": "1506270"
  },
  {
    "text": "the right shows that the results of the question how important sharing real-time",
    "start": "1506270",
    "end": "1512150"
  },
  {
    "text": "data generated by generated by mobile technology is to patients and as you can see 80% of respondents feel it's very",
    "start": "1512150",
    "end": "1520100"
  },
  {
    "text": "important or important to see their data shared back we asked another question about frequency and most would prefer to",
    "start": "1520100",
    "end": "1527300"
  },
  {
    "text": "see it weekly is possible and this confirms data we have gathered from our vision community during our last annual",
    "start": "1527300",
    "end": "1533990"
  },
  {
    "text": "conference where we did live polling with over 400 and families who were in attendance and we asked a question on",
    "start": "1533990",
    "end": "1540500"
  },
  {
    "text": "factors that would most influence a family to join a trial with wearable sensors as we termed it knowing if they",
    "start": "1540500",
    "end": "1547850"
  },
  {
    "text": "were going to receive data back real time to assess their child's activity level was one of the most motivating",
    "start": "1547850",
    "end": "1553820"
  },
  {
    "text": "reasons for them to participate in a wearable trial along with tributing to de-shell natural history",
    "start": "1553820",
    "end": "1559789"
  },
  {
    "text": "research and being able to purchase to participate in other interventional trials at the same time but this doesn't",
    "start": "1559789",
    "end": "1566690"
  },
  {
    "text": "for this want this need in this idea of sharing data back it does not take away from ensuring that this that it does not",
    "start": "1566690",
    "end": "1572779"
  },
  {
    "text": "compromise the integrity of the trial and the safety of the participant to",
    "start": "1572779",
    "end": "1578500"
  },
  {
    "text": "help make this decision about determining if sharing data in real time will impact trial integrity did he",
    "start": "1578799",
    "end": "1585890"
  },
  {
    "text": "created a decision tool to help evaluate whether outcomes data collected should",
    "start": "1585890",
    "end": "1591080"
  },
  {
    "text": "be shared with study participants in real time via the mobile technology it",
    "start": "1591080",
    "end": "1597230"
  },
  {
    "text": "was designed to be used by sponsors and trial designers and partnership with patients and I think this could be a",
    "start": "1597230",
    "end": "1603140"
  },
  {
    "text": "great part of the dialogue between patients and those running trials to enhance thinking communications about",
    "start": "1603140",
    "end": "1608899"
  },
  {
    "text": "the trial as you walk through it you'll see where patient inputs could greatly enhance the decision-making the",
    "start": "1608899",
    "end": "1614840"
  },
  {
    "text": "questions are organized hierarchically and logically walk you through the impacts the real-time outcomes could",
    "start": "1614840",
    "end": "1621110"
  },
  {
    "text": "have a safety quality quality and feasibility of a trial however this tool",
    "start": "1621110",
    "end": "1626419"
  },
  {
    "text": "is not intended to be applicable to every trial nor to be all-inclusive for instance any recognizes the relative",
    "start": "1626419",
    "end": "1633350"
  },
  {
    "text": "ranking of questions may vary according to the nature of the study I recommend that users through the",
    "start": "1633350",
    "end": "1638809"
  },
  {
    "text": "adaptive tool to best meet their needs for more information or other things to",
    "start": "1638809",
    "end": "1644809"
  },
  {
    "text": "consider related to sharing data in real time please see the recommendations recommendations that City put together",
    "start": "1644809",
    "end": "1651049"
  },
  {
    "text": "sections 4-1 and there's a lot more information another hot topic that I",
    "start": "1651049",
    "end": "1660049"
  },
  {
    "text": "thought may under store the importance of participation engagement is data use and we all know that privacy is an",
    "start": "1660049",
    "end": "1666140"
  },
  {
    "text": "important topic to consider stations cannot fully provide informed consent unless they know how their data will be",
    "start": "1666140",
    "end": "1673010"
  },
  {
    "text": "used and this includes real-time data we heard from our previous speaker about",
    "start": "1673010",
    "end": "1678049"
  },
  {
    "text": "understanding how a manufacturer will handle use and store the data is critical in deciding on a technology and",
    "start": "1678049",
    "end": "1684620"
  },
  {
    "text": "platform equally as important is informing patients of how their data will be stored access",
    "start": "1684620",
    "end": "1690150"
  },
  {
    "text": "and by home and sponsors need to understand if there are any limits on how their data might be accessed and",
    "start": "1690150",
    "end": "1696570"
  },
  {
    "text": "used again patients are the expert here and their experience counts it all needs to be laid out in any third-party",
    "start": "1696570",
    "end": "1702660"
  },
  {
    "text": "agreement and included in the informed consent I think it really comes down to",
    "start": "1702660",
    "end": "1707760"
  },
  {
    "text": "trust if there is transparency upfront and how data will be used and access and it is captured all the ingredients and",
    "start": "1707760",
    "end": "1714390"
  },
  {
    "text": "agreements North patients are learning to share in the same city survey than",
    "start": "1714390",
    "end": "1721650"
  },
  {
    "text": "they published in 2017 patients were asked how worried they would be if others besides the research team had",
    "start": "1721650",
    "end": "1728220"
  },
  {
    "text": "access to their data more than fifty percent say they were not worried with another third being only a little",
    "start": "1728220",
    "end": "1733980"
  },
  {
    "text": "worried I would encourage everyone to look at the case study called musi remote smartphone based data collections",
    "start": "1733980",
    "end": "1740250"
  },
  {
    "text": "to broadly share health insights which that found that of nine thousand participants that enrolled in the first",
    "start": "1740250",
    "end": "1746700"
  },
  {
    "text": "six months of a study more than 75 percent opted to broadly share their study data this has been our experience",
    "start": "1746700",
    "end": "1753720"
  },
  {
    "text": "in addition community as well most families and participants if engaged early and included in the",
    "start": "1753720",
    "end": "1758940"
  },
  {
    "text": "decision-making process are supportive of sharing their data for research purposes and understand that we're on",
    "start": "1758940",
    "end": "1764880"
  },
  {
    "text": "the edge of a fundamental change in how we collect outcomes and that can stay could be part of making data collections",
    "start": "1764880",
    "end": "1771030"
  },
  {
    "text": "through mobile technology reality and that this could be a more effective way of conducting clinical trials I also",
    "start": "1771030",
    "end": "1777300"
  },
  {
    "text": "think they're very open to data sharing because of the seriousness of their disease and the difficulty in finding",
    "start": "1777300",
    "end": "1783390"
  },
  {
    "text": "cures most of them feel a real sense of urgency lastly in terms of collecting",
    "start": "1783390",
    "end": "1791160"
  },
  {
    "text": "quality data that it should be developed a table that outlines recommended strategies for optimizing data quality",
    "start": "1791160",
    "end": "1798630"
  },
  {
    "text": "using mobile devices and I want to highlight several that I think really lend themselves to patient engagement",
    "start": "1798630",
    "end": "1803720"
  },
  {
    "text": "the first is formulating the research questions patients need to engage from",
    "start": "1803720",
    "end": "1808890"
  },
  {
    "text": "the very beginning and developing research questions because if they don't feel it's relevant they're not going to",
    "start": "1808890",
    "end": "1814380"
  },
  {
    "text": "participate and the research question this really relates back to deciding what now",
    "start": "1814380",
    "end": "1819970"
  },
  {
    "text": "endpoints because the novel outcome that you're going to be measuring for the device duck is Lee is the selection of",
    "start": "1819970",
    "end": "1826179"
  },
  {
    "text": "the mobile technology this is where the needs and capabilities of the study population need to be included they're",
    "start": "1826179",
    "end": "1832330"
  },
  {
    "text": "the experts and they're what will working well for instance I was just on a call where a sponsor in terms of",
    "start": "1832330",
    "end": "1837820"
  },
  {
    "text": "choices device had not considered whether it needed to be waterproof or not they have not considered whether",
    "start": "1837820",
    "end": "1843730"
  },
  {
    "text": "it's the patient's swim where they get wet where they need to take the device off to do so and if so how much data",
    "start": "1843730",
    "end": "1850360"
  },
  {
    "text": "would be missing if they did it is these types of situations that is overlooked can have a big impact on compliance and",
    "start": "1850360",
    "end": "1856750"
  },
  {
    "text": "data quality service feasibility testing of the protocols to avoiding any",
    "start": "1856750",
    "end": "1862690"
  },
  {
    "text": "unanticipated issues related to data collection as outlined in the past calls it's recommended that a pilot test or",
    "start": "1862690",
    "end": "1869889"
  },
  {
    "text": "the protocol be done so that seems like data attribution area of error data variability and sources of missing data",
    "start": "1869889",
    "end": "1875919"
  },
  {
    "text": "can be uncovered in remedy before the actual trial starts ensuring quality data and of course this needs to be done",
    "start": "1875919",
    "end": "1882700"
  },
  {
    "text": "with the actual users the URL in this slide contains the complete table of recommended strategies for optimizing",
    "start": "1882700",
    "end": "1888549"
  },
  {
    "text": "data quality and it's a great resource so in summary we're in an exciting time",
    "start": "1888549",
    "end": "1895240"
  },
  {
    "text": "and I'm very optimistic about how mobile technologies can change how to collect outcomes and clinical trials and I'm",
    "start": "1895240",
    "end": "1901899"
  },
  {
    "text": "really looking forward to see where we are in the next five to ten years and now I'm going to turn it back over to",
    "start": "1901899",
    "end": "1907690"
  },
  {
    "text": "race thank you very much Abby when",
    "start": "1907690",
    "end": "1912850"
  },
  {
    "text": "thinking about appliance recommendations we should just remember that the recognition should be applied consistent",
    "start": "1912850",
    "end": "1918730"
  },
  {
    "text": "with the same principles of good clinical practice with hear adherence to scientific principles data quality and",
    "start": "1918730",
    "end": "1925509"
  },
  {
    "text": "participant engagement and a good analogy for the use of mobile technologies is just to think about how",
    "start": "1925509",
    "end": "1931090"
  },
  {
    "text": "imaging has been incorporated in clinical trials over the last 25 years and many of the same issues especially",
    "start": "1931090",
    "end": "1937690"
  },
  {
    "text": "around data collection data management protocol to design and FDA submission inspection and selection of the imaging",
    "start": "1937690",
    "end": "1945730"
  },
  {
    "text": "modality would apply to mobile technologies as well and",
    "start": "1945730",
    "end": "1952640"
  },
  {
    "text": "disruption that's been enabled by these mobile technologies is not only changing clinical trials is changing clinical",
    "start": "1952640",
    "end": "1958520"
  },
  {
    "text": "care and made the research studies that are being done well quickly I think find",
    "start": "1958520",
    "end": "1963860"
  },
  {
    "text": "them find their way into affecting the way we care for patients just three",
    "start": "1963860",
    "end": "1969080"
  },
  {
    "text": "studies that are worth noting is one one highlighted here is a collaboration between barely Stanford and Duke does",
    "start": "1969080",
    "end": "1976400"
  },
  {
    "text": "collect data from ten thousand participants including clinical imaging and self-reported data as well as data",
    "start": "1976400",
    "end": "1983390"
  },
  {
    "text": "from sensors that can assess sleep and activity a second study is the Apple",
    "start": "1983390",
    "end": "1989930"
  },
  {
    "text": "Heart Study which is another ongoing study using Apple watch to identify individuals with a colt atrial",
    "start": "1989930",
    "end": "1996560"
  },
  {
    "text": "fibrillation who can then be connected to a clinician over videoconferencing over their watch and then be guided as",
    "start": "1996560",
    "end": "2004270"
  },
  {
    "text": "to whether cardiology follow-up is necessary and finally the NIH is sponsoring the all of us study which is",
    "start": "2004270",
    "end": "2011230"
  },
  {
    "text": "seeking to gather health data on 1 million research participants through",
    "start": "2011230",
    "end": "2016690"
  },
  {
    "text": "various modalities including mobile technologies all of these point to the immense ability to drive scale and",
    "start": "2016690",
    "end": "2024040"
  },
  {
    "text": "clinical studies that previously was really inconceivable and all of them also highlight the potential that when",
    "start": "2024040",
    "end": "2030880"
  },
  {
    "text": "these technologies are used in clinical trials they will likely migrate their way into use into clinical care so what",
    "start": "2030880",
    "end": "2038980"
  },
  {
    "text": "can you do next you can access the recommendations and resources including many that abby and",
    "start": "2038980",
    "end": "2046380"
  },
  {
    "text": "linda highlighted earlier and if you have any questions you can contact city",
    "start": "2046380",
    "end": "2052540"
  },
  {
    "text": "and their outstanding project manager jennifer gold sac who is well-equipped",
    "start": "2052540",
    "end": "2060398"
  },
  {
    "text": "to answer any questions that you have and does so in a very responsive and friendly and british way and the general",
    "start": "2060399",
    "end": "2067510"
  },
  {
    "text": "email for city is provided they're provided there with that I'll turn it",
    "start": "2067510",
    "end": "2073060"
  },
  {
    "text": "over to Lee Lita to handle of the questions and answers great thank you so",
    "start": "2073060",
    "end": "2078940"
  },
  {
    "text": "much red ok so let's move on to the Q&A section now there is still time to",
    "start": "2078940",
    "end": "2085330"
  },
  {
    "text": "submit your question by using the Q&A button at the bottom of your screen and we have a lot of great",
    "start": "2085330",
    "end": "2091299"
  },
  {
    "text": "questions already so we're going to try to get to as many as possible so our",
    "start": "2091299",
    "end": "2096908"
  },
  {
    "text": "first question is for addy addy you share that it may not always be appropriate to share outcomes data in",
    "start": "2096909",
    "end": "2104440"
  },
  {
    "text": "real time with study participants how can we promote patient engagement and",
    "start": "2104440",
    "end": "2109750"
  },
  {
    "text": "acceptance of the technology in these cases that's a great question so I'm",
    "start": "2109750",
    "end": "2116920"
  },
  {
    "text": "assuming first of all that the reason you wouldn't want to share the outcomes back real time is for a safety concern",
    "start": "2116920",
    "end": "2124150"
  },
  {
    "text": "or for a possible it could influence study behavior and then you biased your results so first of all there's other",
    "start": "2124150",
    "end": "2131260"
  },
  {
    "text": "things that you could really do before the trial even starts and we talked a little bit about the research question",
    "start": "2131260",
    "end": "2136510"
  },
  {
    "text": "and getting patients involved upfront maybe doing a focus group on developing the outcome and the research question so",
    "start": "2136510",
    "end": "2142750"
  },
  {
    "text": "that it's in patient engagement you can do right there and then you know working",
    "start": "2142750",
    "end": "2149049"
  },
  {
    "text": "with them through the informed consent process and discussing or making clear",
    "start": "2149049",
    "end": "2154059"
  },
  {
    "text": "that at the end what data you will provide at the end of the trial and why you're not providing its during the",
    "start": "2154059",
    "end": "2159670"
  },
  {
    "text": "trials those are a couple things you can do before and after and there might be able there might be data that you could",
    "start": "2159670",
    "end": "2168029"
  },
  {
    "text": "provide back to the participant during the trial that does not interfere with",
    "start": "2168029",
    "end": "2174450"
  },
  {
    "text": "behavior of providing safety concern so we've discussed things like there could be some compliance data or you're 45%",
    "start": "2174450",
    "end": "2182950"
  },
  {
    "text": "way through the trial data this motive you know in encouragement data or pass",
    "start": "2182950",
    "end": "2189220"
  },
  {
    "text": "on the back.this job that you have to assess it with the patients of course but that that type of data might be able",
    "start": "2189220",
    "end": "2196690"
  },
  {
    "text": "to be provided back to the patient during the trial so those are just some ideas anybody else",
    "start": "2196690",
    "end": "2203760"
  },
  {
    "text": "and of course Rey is you were mentioning as overtime mobile devices become more",
    "start": "2204089",
    "end": "2209890"
  },
  {
    "text": "of the standard of care we can look then to implement patient feedback as",
    "start": "2209890",
    "end": "2216069"
  },
  {
    "text": "appropriate to help patients get some better outcomes faster yes and again they now thinking about",
    "start": "2216069",
    "end": "2221710"
  },
  {
    "text": "blood glucose levels and probably initially that data was initially shared with research participants and then",
    "start": "2221710",
    "end": "2228460"
  },
  {
    "text": "became more and more mainstream and now patients control that and have self management of their own conditions",
    "start": "2228460",
    "end": "2236460"
  },
  {
    "text": "excellent thank you this next question I'll ask Linda to start us off for regulatory purposes how",
    "start": "2237180",
    "end": "2245050"
  },
  {
    "text": "can it be verified that mobile devices that were used to collect data we're used only by the study participants and",
    "start": "2245050",
    "end": "2252880"
  },
  {
    "text": "Linda after you answer that Ray I'm going to turn that to you to go a little bit deeper into the two-phase approach",
    "start": "2252880",
    "end": "2258580"
  },
  {
    "text": "that City recommends but first let's start out with the first part of that question Linda thank you I first it's",
    "start": "2258580",
    "end": "2268750"
  },
  {
    "text": "important to think about you know how you're selecting your device and make sure that you the device that you're",
    "start": "2268750",
    "end": "2275410"
  },
  {
    "text": "selecting allows for the appropriate controls that you would need in order to",
    "start": "2275410",
    "end": "2280660"
  },
  {
    "text": "assess that the data that you are getting is from the participant that you",
    "start": "2280660",
    "end": "2286540"
  },
  {
    "text": "expect so there are digital tools that are available through some kind of login",
    "start": "2286540",
    "end": "2294340"
  },
  {
    "text": "mechanism or some other authentication principles that would allow you to",
    "start": "2294340",
    "end": "2300580"
  },
  {
    "text": "basically trust the data that you are getting being from the person that you",
    "start": "2300580",
    "end": "2305650"
  },
  {
    "text": "think it's from so that's certainly a way to start and you know again it's",
    "start": "2305650",
    "end": "2312670"
  },
  {
    "text": "starting with the selection of your tool and making sure that your the tool that",
    "start": "2312670",
    "end": "2318130"
  },
  {
    "text": "you pick allows you to measure what you want to measure and the way that you want to measure it right and Ray q can",
    "start": "2318130",
    "end": "2326680"
  },
  {
    "text": "you address the two-phase approach that he recommends sure so City recommends a two phases one is a thoughtful design",
    "start": "2326680",
    "end": "2334540"
  },
  {
    "text": "that promotes compliance and the second is authentication through the technology",
    "start": "2334540",
    "end": "2339550"
  },
  {
    "text": "as Linda referenced so I can give you a couple examples so we did a study with a",
    "start": "2339550",
    "end": "2345220"
  },
  {
    "text": "smartphone for measuring Parkinson disease and it turns out that either",
    "start": "2345220",
    "end": "2350680"
  },
  {
    "text": "tests of your gait or your or just finger tapping you leave a",
    "start": "2350680",
    "end": "2355779"
  },
  {
    "text": "digital fingerprint so I'm six foot five and so my gait is going to look a lot different than somebody who isn't six",
    "start": "2355779",
    "end": "2362410"
  },
  {
    "text": "foot five and so I might have longer fingers and somebody who is shorter in",
    "start": "2362410",
    "end": "2368369"
  },
  {
    "text": "addition it's also worth remembering that there are substantial shortcomings authentication with our current measures",
    "start": "2368369",
    "end": "2374499"
  },
  {
    "text": "so for example participant Diaries there's little assurance that the people who are completing those diaries or one",
    "start": "2374499",
    "end": "2380890"
  },
  {
    "text": "necessary the research participant and to when they're being when and where they're being conducted and our digital",
    "start": "2380890",
    "end": "2387309"
  },
  {
    "text": "tools allow you know time and date stamping and you have authentication such as passwords that can be used to",
    "start": "2387309",
    "end": "2394059"
  },
  {
    "text": "determine the person or increase the likelihood of the person completing theirs outcome measures are is indeed a",
    "start": "2394059",
    "end": "2400450"
  },
  {
    "text": "research participant excellent thank you and you know Rackham the paper that you",
    "start": "2400450",
    "end": "2407769"
  },
  {
    "text": "shared earlier about the study that Roche did this year one of the things that was interesting is how the digital",
    "start": "2407769",
    "end": "2413859"
  },
  {
    "text": "capture had greater sensitivity than the paper-based tools and classifying some",
    "start": "2413859",
    "end": "2419289"
  },
  {
    "text": "of those patients progression on certain disease scale maybe you could just comment briefly do you think that these",
    "start": "2419289",
    "end": "2425589"
  },
  {
    "text": "technologies will give us greater insights into disease states go in the pores yeah I would just point out in the game",
    "start": "2425589",
    "end": "2432279"
  },
  {
    "text": "with glucose you know we didn't even know about nocturnal hypo hypo and hyper glycemia until we bothered to measure",
    "start": "2432279",
    "end": "2438369"
  },
  {
    "text": "blood glucoses at night we didn't know much about sleep disorders until we bothered to observe people sleeping we",
    "start": "2438369",
    "end": "2445239"
  },
  {
    "text": "didn't know about blood pressure variability until we started measuring blood pressure frequently and these tools are and give us an enormous window",
    "start": "2445239",
    "end": "2451930"
  },
  {
    "text": "into what happens in the 99.9% of the time that people aren't in clinic and that our assessments done in clinic are",
    "start": "2451930",
    "end": "2459670"
  },
  {
    "text": "done at arbitrary times and artificial environments and that these digital tools can give us real-world assessments",
    "start": "2459670",
    "end": "2467049"
  },
  {
    "text": "on how people are functioning Thank You",
    "start": "2467049",
    "end": "2472200"
  },
  {
    "text": "Linda in and your slides you mentioned that you shouldn't have to worry about",
    "start": "2472200",
    "end": "2480489"
  },
  {
    "text": "the mobile device being validated can you expand on that what we will",
    "start": "2480489",
    "end": "2485920"
  },
  {
    "text": "we'll study designers need to use medical grade devices thank you yes",
    "start": "2485920",
    "end": "2495109"
  },
  {
    "text": "if I said that I think it was a little",
    "start": "2495109",
    "end": "2500420"
  },
  {
    "text": "bit out of context perhaps certainly the sensors and the processing and",
    "start": "2500420",
    "end": "2506559"
  },
  {
    "text": "absolutely the outcome measure itself all need to be validated we are talking",
    "start": "2506559",
    "end": "2512750"
  },
  {
    "text": "about verification versus validation we are talking about in this context the",
    "start": "2512750",
    "end": "2518950"
  },
  {
    "text": "verification is looking at the accuracy of the sensor data itself while the",
    "start": "2518950",
    "end": "2525200"
  },
  {
    "text": "outcome measurement was being validated to make sure it's the right use in the tool or excuse me the right use for the",
    "start": "2525200",
    "end": "2532759"
  },
  {
    "text": "study and and no none of these need to be medical grade per se they need to be",
    "start": "2532759",
    "end": "2540920"
  },
  {
    "text": "the right tool for the study clinical studies can use devices that help them",
    "start": "2540920",
    "end": "2549109"
  },
  {
    "text": "to measure outcomes without those tools being cleared or approved as medical",
    "start": "2549109",
    "end": "2556759"
  },
  {
    "text": "devices themselves but that doesn't mean that the outcome that's being measured",
    "start": "2556759",
    "end": "2564140"
  },
  {
    "text": "to support the clinical trial should not be validated and demonstrated to support the overall use in the clinical trial so",
    "start": "2564140",
    "end": "2572839"
  },
  {
    "text": "when we are talking about verification we're talking about the accuracy of the measurements themselves and in",
    "start": "2572839",
    "end": "2579140"
  },
  {
    "text": "validation we are talking about the accuracy of the utility of the outcome",
    "start": "2579140",
    "end": "2586940"
  },
  {
    "text": "assessment itself I hope that makes more sense thank you for clarifying that",
    "start": "2586940",
    "end": "2593680"
  },
  {
    "text": "good Abby what kind of support do you need to give patients when you provide",
    "start": "2593680",
    "end": "2598700"
  },
  {
    "text": "them with mobile technologies um well first of all I think right off the bat",
    "start": "2598700",
    "end": "2605119"
  },
  {
    "text": "is it a pediatric population or natal population because that makes a difference but upfront training I think",
    "start": "2605119",
    "end": "2612410"
  },
  {
    "text": "that's really important to including webinars and having a really good",
    "start": "2612410",
    "end": "2618900"
  },
  {
    "text": "support 800 numbers and customer service that are available it's really a very",
    "start": "2618900",
    "end": "2625049"
  },
  {
    "text": "not like a narrow time frame but accessible I think just with the upfront",
    "start": "2625049",
    "end": "2631529"
  },
  {
    "text": "training and then having a good customer service to support team available that's",
    "start": "2631529",
    "end": "2637740"
  },
  {
    "text": "a good a good start actually thank you",
    "start": "2637740",
    "end": "2642809"
  },
  {
    "text": "great help you yeah go ahead right so I agree completely with the points just",
    "start": "2642809",
    "end": "2650400"
  },
  {
    "text": "provided we train them participants at the at the site we provide online videos",
    "start": "2650400",
    "end": "2656910"
  },
  {
    "text": "for participants we try to provide not quite 24/7 access but we provide a",
    "start": "2656910",
    "end": "2663990"
  },
  {
    "text": "dedicated a telephone line for participants to contact sometimes we",
    "start": "2663990",
    "end": "2669180"
  },
  {
    "text": "take that activity off the site so the site coordinators don't necessarily have to worry about all the details of the",
    "start": "2669180",
    "end": "2676200"
  },
  {
    "text": "technology and that can be a centralized process we also have email and FA cues",
    "start": "2676200",
    "end": "2682440"
  },
  {
    "text": "on the website as long long with videos to help participants all that said still",
    "start": "2682440",
    "end": "2688890"
  },
  {
    "text": "sometimes people run into difficulties but that's it those are some of the things that we've use great and Rea",
    "start": "2688890",
    "end": "2695910"
  },
  {
    "text": "another question for you what is the thought around using mobile technologies for studies and populations where",
    "start": "2695910",
    "end": "2702720"
  },
  {
    "text": "there's limited access to the Internet yeah so I have a great answer here but the digital divide the differential",
    "start": "2702720",
    "end": "2709230"
  },
  {
    "text": "access to the Internet and mobile technologies based on social Geographic and economic factors is a huge issue and",
    "start": "2709230",
    "end": "2715470"
  },
  {
    "text": "can be really a huge issue depending on the disease or patient population that one is studying we try as much as",
    "start": "2715470",
    "end": "2723329"
  },
  {
    "text": "possible to give people devices that will work independent of where they are and sometimes people have given Wi-Fi",
    "start": "2723329",
    "end": "2731700"
  },
  {
    "text": "routers into people's homes to facilitate use of it",
    "start": "2731700",
    "end": "2738380"
  },
  {
    "text": "I'm remain interested in see here what others have to say as well we've largely",
    "start": "2739099",
    "end": "2747000"
  },
  {
    "text": "been able to engage us about everyone but if you look at the people who've been poor just paying in many of our observational",
    "start": "2747000",
    "end": "2753160"
  },
  {
    "text": "studies they clearly don't represent the general population they tend to be far more educated than the general",
    "start": "2753160",
    "end": "2758980"
  },
  {
    "text": "population for more white than the general population far more familiar",
    "start": "2758980",
    "end": "2764140"
  },
  {
    "text": "with the internet the general population okay so that's an important point to",
    "start": "2764140",
    "end": "2770859"
  },
  {
    "text": "think about when you think about the selection for trials and inland is there anything that you'd add for us yeah I",
    "start": "2770859",
    "end": "2778900"
  },
  {
    "text": "just to echo you know raise thoughts it's important to think about ways to",
    "start": "2778900",
    "end": "2786190"
  },
  {
    "text": "engage those patients in in trials as well so when you're thinking about you",
    "start": "2786190",
    "end": "2793180"
  },
  {
    "text": "know what measure you're going to use the tool for or how you're going to use",
    "start": "2793180",
    "end": "2798970"
  },
  {
    "text": "your mobile technology thinking about what can be stored with the technology",
    "start": "2798970",
    "end": "2805570"
  },
  {
    "text": "and download it at a later point you know what has to be done in real time",
    "start": "2805570",
    "end": "2810730"
  },
  {
    "text": "such that a connection is always necessary and and just thinking through",
    "start": "2810730",
    "end": "2816190"
  },
  {
    "text": "are there ways to use the technology to make sure that you are engaging people",
    "start": "2816190",
    "end": "2823420"
  },
  {
    "text": "in these more remote sites thank you and Abby I'm curious what your perspective",
    "start": "2823420",
    "end": "2829600"
  },
  {
    "text": "is on how we reach in patients who are perhaps in these areas without access",
    "start": "2829600",
    "end": "2835800"
  },
  {
    "text": "yeah it's a it's a very is a question that we pondered not only in the context",
    "start": "2835800",
    "end": "2842109"
  },
  {
    "text": "of doing mobile technology study but just getting them into the clinic you",
    "start": "2842109",
    "end": "2847630"
  },
  {
    "text": "know I mean there's all we're always that's that's the age-old question have you reached the underserved in the very",
    "start": "2847630",
    "end": "2855030"
  },
  {
    "text": "sort of preliminary workings that we're doing with mobile device studies in our",
    "start": "2855030",
    "end": "2860170"
  },
  {
    "text": "patient population we're recruiting or we plan to recruit through auditions registry so that is an online resource",
    "start": "2860170",
    "end": "2867310"
  },
  {
    "text": "to begin with so we're kind of by default already starting with a population that is internet literate so",
    "start": "2867310",
    "end": "2875440"
  },
  {
    "text": "to speak so but I agree with all what everyone else is that it's really important to try to think of ways that",
    "start": "2875440",
    "end": "2883570"
  },
  {
    "text": "we could engage patience even when they don't have internet access",
    "start": "2883570",
    "end": "2889770"
  },
  {
    "text": "great thank you so this next question is for ray usability matters for the",
    "start": "2889770",
    "end": "2896290"
  },
  {
    "text": "patient population what if one of the subpopulations has better usability with",
    "start": "2896290",
    "end": "2901450"
  },
  {
    "text": "one device and another subpopulation has better usability with a difference of",
    "start": "2901450",
    "end": "2906610"
  },
  {
    "text": "ice but collecting the same data what are the considerations for this scenario",
    "start": "2906610",
    "end": "2912150"
  },
  {
    "text": "I haven't seen this yet we have one observational study in which North",
    "start": "2912150",
    "end": "2919660"
  },
  {
    "text": "American participants are using one device and the European participants are using a different device obviously the",
    "start": "2919660",
    "end": "2926290"
  },
  {
    "text": "data that are being collected if say gate will presumably differ obviously if",
    "start": "2926290",
    "end": "2932650"
  },
  {
    "text": "that's the case you want to have you know preliminary data suggesting that both devices are measuring gait in a",
    "start": "2932650",
    "end": "2938590"
  },
  {
    "text": "very similar way I think I would be cautious here it's I would use analogy",
    "start": "2938590",
    "end": "2944710"
  },
  {
    "text": "to imaging so if you were using one set of imaging for one set of population",
    "start": "2944710",
    "end": "2949870"
  },
  {
    "text": "another set of imaging for another or different population because of usability or whatever the consideration",
    "start": "2949870",
    "end": "2955540"
  },
  {
    "text": "I think I would be a little bit concerned unless I had really good data suggesting that those two different",
    "start": "2955540",
    "end": "2962050"
  },
  {
    "text": "devices two different imaging modalities were had data prior to the study",
    "start": "2962050",
    "end": "2968890"
  },
  {
    "text": "suggesting that they were indeed comparable Lindon might have additional thoughts from the FDA Antonio you have",
    "start": "2968890",
    "end": "2978880"
  },
  {
    "text": "to determine whether the subpopulations are different in some way right and you",
    "start": "2978880",
    "end": "2985510"
  },
  {
    "text": "know is it is it a matter of the subpopulations being different or the devices being different so taking the",
    "start": "2985510",
    "end": "2992800"
  },
  {
    "text": "time to tease out you know where the",
    "start": "2992800",
    "end": "2998530"
  },
  {
    "text": "difference really is I think it's key and I think is a challenge you know I appreciate you know raised discussion of",
    "start": "2998530",
    "end": "3007230"
  },
  {
    "text": "this topic and how he would deal with it in a real trial great thank you",
    "start": "3007230",
    "end": "3015270"
  },
  {
    "text": "well I want to thank everyone for a ten being this fierce markets webinar and",
    "start": "3015270",
    "end": "3021910"
  },
  {
    "text": "submitting so many great questions I'd like to thank Rage Abbi and Linda for",
    "start": "3021910",
    "end": "3028110"
  },
  {
    "text": "participating and city for helping to accelerate transformation in the",
    "start": "3028110",
    "end": "3033370"
  },
  {
    "text": "industry and just as a reminder for our attendees we have recorded this webinar",
    "start": "3033370",
    "end": "3038800"
  },
  {
    "text": "and you're going to be able to access the recording within 24 hours using the",
    "start": "3038800",
    "end": "3044440"
  },
  {
    "text": "same audience link that we sent to you earlier thank you all again for joining and we look forward to seeing you at",
    "start": "3044440",
    "end": "3050770"
  },
  {
    "text": "future events",
    "start": "3050770",
    "end": "3053160"
  }
]